Effectiveness and Tolerability of Bezafibrate in Primary Biliary Cholangitis: A Nationwide Real-World Study

In this real-world nationwide study, the one-year fibrate discontinuation rate was substantial. However off-label use of bezafibrate was associated with reductions in the biochemical markers of cholestasis in PBC, which were associated with clinical outcome in this setting of second line therapy.

Authors

Institutions

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-12-09
DOI
https://doi.org/10.14309/ajg.0000000000003879
Citations
1
Primary Topic
Liver Diseases and Immunity
Type
article
Field-Weighted Citation Impact
1.32
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effectiveness and Tolerability of Bezafibrate in Primary Biliary Cholangitis: A Nationwide Real-World Study

Philip W. Friederich, Frans J.C. Cuperus, Jan Maarten Vrolijk, Jerome Sint Nicolaas et al.
1 citations
The American Journal of Gastroenterology
Liver Diseases and Immunity
1.32
article

Effectiveness and Tolerability of Bezafibrate in Primary Biliary Cholangitis: A Nationwide Real-World Study

Philip W. Friederich, Frans J.C. Cuperus, Jan Maarten Vrolijk, Jerome Sint Nicolaas, Hüseyin Aktaş, Robert C. Verdonk, Ulrich H. Beuers, Nicole S. Erler, Tom J.G. Gevers, Bettina E. Hansen, Hajo J. Flink, Maria C. van Hooff, Sunje Abraham, J. Marleen de Vree, Elsemieke S. de Vries, Harry L.A. Janssen, Adriaan van der Meer, Rozanne C. de Veer, Merel M. Tielemans, Cyriel Y. Ponsioen, Ulrike de Wit, Daphne M. Hotho, E. Werner, Ynto S. de Boer, Joost P.H. Drenth, Yasser A. Alderlieste, Michael Klemt‐Kropp, Marjo J. Kerbert-Dreteler, Stephan Schmittgens, Johan Kuijvenhoven, Bart van Hoek, Edith M.M. Kuiper, Bart J. Veldt, Suzanne van Meer, Janne E. van Rooij
article en
1 citations

Abstract

In this real-world nationwide study, the one-year fibrate discontinuation rate was substantial. However off-label use of bezafibrate was associated with reductions in the biochemical markers of cholestasis in PBC, which were associated with clinical outcome in this setting of second line therapy.

The American Journal of Gastroenterology
University Medical Center Groningen (NL), Radboud University Nijmegen (NL), Leiden University Medical Center (NL), Maastricht University Medical Centre (NL), Catharina Ziekenhuis (NL), Medisch Spectrum Twente (NL), Erasmus MC (NL), Radboud University Medical Center (NL), University Medical Center Utrecht (NL), Maastricht University (NL), Noordwest Ziekenhuisgroep (NL), Reinier de Graaf Hospital (NL), Spaarne Ziekenhuis (NL), Alrijne Ziekenhuis (NL), St. Antonius Ziekenhuis (NL), Amphia Ziekenhuis (NL), Maasstad Ziekenhuis (NL), Treant Zorggroep (NL), Ziekenhuis Nij Smellinghe (NL), Beatrix Kinderziekenhuis (NL), Isala (NL), Elisabeth-TweeSteden Ziekenhuis (NL), Ziekenhuis Groep Twente (NL), Amsterdam University Medical Centers (NL), Rijnstate Hospital (NL), Meander Medisch Centrum (NL), 's Heeren Loo (NL), Bravis Ziekenhuis (NL), Spaarne Gasthuis (NL)
Openalex Percentile: Top 14%
Liver Diseases and Immunity
1.32
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.